4qev: Difference between revisions

Line 1:

'''~~Unreleased structure~~'''

==Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE)==

~~The entry~~ 4qev is ~~ON HOLD until Paper Publication~~

== Structural highlights ==

<table><tr><td colspan='2'>[[4qev]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QEV OCA]. For a guided tour on the structure components use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QEV FirstGlance].

~~Authors~~: ~~Tallant~~, C., ~~Baud~~, M., ~~Lin~~-~~Shiao~~, E., Chirgadze, D.Y., Ciulli, A.

</td></tr><tr id='ligand'><td class="sblockLbl">[[Ligand|Ligands:]]</td><td class="sblockDat"><scene name='pdbligand=2PE:NONAETHYLENE+GLYCOL'>2PE</scene>, <scene name='pdbligand=31O:METHYL+(2R)-2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1,4]BENZODIAZEPIN-4-YL]PROPANOATE'>31O</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene></td></tr>

<tr id='related'><td class="sblockLbl">[[Related_structure|Related:]]</td><td class="sblockDat">[[4qep|4qep]]</td></tr>

~~Description~~:

<tr id='resources'><td class="sblockLbl">Resources:</td><td class="sblockDat">[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qev FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qev OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qev RCSB], [http://www.ebi.ac.uk/pdbsum/4qev PDBsum]</td></tr>

</table>

__TOC__

</StructureSection>

[[Category: Baud, M.]]

[[Category: Chirgadze, D Y.]]

[[Category: Ciulli, A.]]

[[Category: Lin-Shiao, E.]]

[[Category: Tallant, C.]]

[[Category: Bromodomain-containing protein 2]]

[[Category: Kiaa9001]]

[[Category: Ring3]]

[[Category: Transcription regulation]]

[[Category: Transcription-transcription inhibitor complex]]

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+==Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE)==
+<StructureSection load='4qev' size='340' side='right' caption='[[4qev]], [[Resolution|resolution]] 1.80&Aring;' scene=''>
-The entry 4qev is ON HOLD  until Paper Publication
+== Structural highlights ==
+<table><tr><td colspan='2'>[[4qev]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QEV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QEV FirstGlance]. <br>
-Authors: Tallant, C., Baud, M., Lin-Shiao, E., Chirgadze, D.Y., Ciulli, A.
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2PE:NONAETHYLENE+GLYCOL'>2PE</scene>, <scene name='pdbligand=31O:METHYL+(2R)-2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1,4]BENZODIAZEPIN-4-YL]PROPANOATE'>31O</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene></td></tr>
+<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qep|4qep]]</td></tr>
-Description:
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qev FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qev OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qev RCSB], [http://www.ebi.ac.uk/pdbsum/4qev PDBsum]</span></td></tr>
+</table>
+__TOC__
+</StructureSection>
+[[Category: Baud, M.]]
+[[Category: Chirgadze, D Y.]]
+[[Category: Ciulli, A.]]
+[[Category: Lin-Shiao, E.]]
+[[Category: Tallant, C.]]
+[[Category: Bromodomain-containing protein 2]]
+[[Category: Kiaa9001]]
+[[Category: Ring3]]
+[[Category: Transcription regulation]]
+[[Category: Transcription-transcription inhibitor complex]]